PD1 Blockade in Cancer: Impact on Myeloid Cells.

Fujiwara, Mai; Garo, Lucien P; Murugaiyan, Gopal

Fujiwara, Mai; Garo, Lucien P; Murugaiyan, Gopal.

Afiliación

Fujiwara M; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Garo LP; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Murugaiyan G; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: mgopal@rics.bwh.harvard.edu.

Trends Cancer ; 6(6): 443-444, 2020 06.

Article en En | MEDLINE | ID: mdl-32459997

Asunto(s)

Neoplasias; Receptor de Muerte Celular Programada 1; Humanos; Células Mieloides; Transducción de Señal; Linfocitos T

Palabras clave

PD1; T cells; antitumor immunity; dendritic cells (DCs); myeloid cells; myeloid-derived suppressor cells (MDSCs)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Neoplasias Límite: Humans Idioma: En Revista: Trends Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google